Postoperative adjuvant radiotherapy for breast ductal carcinoma in situ / 国际肿瘤学杂志
Journal of International Oncology
; (12): 928-931, 2012.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-429621
Responsible library:
WPRO
ABSTRACT
Breast-conserving surgery (BCS) has become the most common treatment for breast ductal carcinoma in situ (DCIS).BCS followed by radiotherapy (RT) can reduce the risk of recurrence.However,controversy exists regarding the region of RT,which low-risk patients can avoid RT after BCS,and the role of accelerated partial breast irradiation (APBI) in the treatment of BCS.However,most trials have indicated that all DCIS patients can obtain benefit from RT after BCS.Further prospective studies are warranted to identify whether RT can be safely omitted for low-risk patients with DCIS.Long-term results of ongoing studies on outcome of BCS alone suggest that RT should be routinely recommended after BCS for all patients except those with contraindication.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Observational study
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2012
Document type:
Article